APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Bioanalytical Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell and Gene Therapy Bioanalytical Testing Services Market Analysis and Forecast 2026-2032

4 March 2026195 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Bioanalytical Testing Services Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Bioanalytical Testing Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Bioanalytical Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Bioanalytical Testing Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Bioanalytical Testing Services Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Bioanalytical Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell and Gene Therapy Bioanalytical Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell and Gene Therapy Bioanalytical Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell and Gene Therapy Bioanalytical Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell and Gene Therapy Bioanalytical Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell and Gene Therapy Bioanalytical Testing Services include BioAgilytix Labs, KCAS Bioanalytical Services, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, Inc., Prolytix, Pharmaron, Charles River Laboratories, Syneos Health and SGS SA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell and Gene Therapy Bioanalytical Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell and Gene Therapy Bioanalytical Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell and Gene Therapy Bioanalytical Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell and Gene Therapy Bioanalytical Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell and Gene Therapy Bioanalytical Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell and Gene Therapy Bioanalytical Testing Services revenue, projected growth trends, production technology, application and end-user industry.

Cell and Gene Therapy Bioanalytical Testing Services Segment by Company

BioAgilytix Labs

KCAS Bioanalytical Services

Laboratory Corporation of America Holdings

Pharmaceutical Product Development, Inc.

Prolytix

Pharmaron

Charles River Laboratories

Syneos Health

SGS SA

CD BioSciences

Cell and Gene Therapy Bioanalytical Testing Services Segment by Type

Gene Therapy

Gene-modified Cell Therapy

Cell Therapy

Cell and Gene Therapy Bioanalytical Testing Services Segment by Application

Non-clinical Contract Manufacturing Organizations

Pharma and Biopharma Companies

Contract Research Organizations

Others

Cell and Gene Therapy Bioanalytical Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Bioanalytical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Bioanalytical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Bioanalytical Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell and Gene Therapy Bioanalytical Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell and Gene Therapy Bioanalytical Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Bioanalytical Testing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Therapy Major Player Table 3. Gene-modified Cell Therapy Major Player Table 4. Cell Therapy Major Player Table 5. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Non-clinical Contract Manufacturing Organizations Major Player Table 7. Pharma and Biopharma Companies Major Player Table 8. Contract Research Organizations Major Player Table 9. Others Major Player Table 10. Cell and Gene Therapy Bioanalytical Testing Services Industry Trends Table 11. Cell and Gene Therapy Bioanalytical Testing Services Industry Drivers Table 12. Cell and Gene Therapy Bioanalytical Testing Services Industry Opportunities and Challenges Table 13. Cell and Gene Therapy Bioanalytical Testing Services Industry Restraints Table 14. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Region (2021-2026) Table 17. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Region (2027-2032) Table 19. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Players (2021-2026) Table 21. Global Cell and Gene Therapy Bioanalytical Testing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Cell and Gene Therapy Bioanalytical Testing Services Key Players Headquarters & Area Served Table 23. Global Cell and Gene Therapy Bioanalytical Testing Services Players, Product Type & Application Table 24. Global Cell and Gene Therapy Bioanalytical Testing Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Cell and Gene Therapy Bioanalytical Testing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2021-2026) Table 31. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2027-2032) Table 32. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2021-2026) Table 36. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2027-2032) Table 37. BioAgilytix Labs Company Information Table 38. BioAgilytix Labs Business Overview Table 39. BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 41. BioAgilytix Labs Recent Development Table 42. KCAS Bioanalytical Services Company Information Table 43. KCAS Bioanalytical Services Business Overview Table 44. KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 46. KCAS Bioanalytical Services Recent Development Table 47. Laboratory Corporation of America Holdings Company Information Table 48. Laboratory Corporation of America Holdings Business Overview Table 49. Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 51. Laboratory Corporation of America Holdings Recent Development Table 52. Pharmaceutical Product Development, Inc. Company Information Table 53. Pharmaceutical Product Development, Inc. Business Overview Table 54. Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 56. Pharmaceutical Product Development, Inc. Recent Development Table 57. Prolytix Company Information Table 58. Prolytix Business Overview Table 59. Prolytix Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Prolytix Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 61. Prolytix Recent Development Table 62. Pharmaron Company Information Table 63. Pharmaron Business Overview Table 64. Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 66. Pharmaron Recent Development Table 67. Charles River Laboratories Company Information Table 68. Charles River Laboratories Business Overview Table 69. Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 71. Charles River Laboratories Recent Development Table 72. Syneos Health Company Information Table 73. Syneos Health Business Overview Table 74. Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 76. Syneos Health Recent Development Table 77. SGS SA Company Information Table 78. SGS SA Business Overview Table 79. SGS SA Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. SGS SA Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 81. SGS SA Recent Development Table 82. CD BioSciences Company Information Table 83. CD BioSciences Business Overview Table 84. CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 86. CD BioSciences Recent Development Table 87. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 101. China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 102. China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 103. China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 104. China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Bioanalytical Testing Services Image Figure 2. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Gene-modified Cell Therapy Image Figure 6. Cell Therapy Image Figure 7. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Non-clinical Contract Manufacturing Organizations Image Figure 10. Pharma and Biopharma Companies Image Figure 11. Contract Research Organizations Image Figure 12. Others Image Figure 13. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Cell and Gene Therapy Bioanalytical Testing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2021-2032) Figure 21. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2021-2032) Figure 24. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032) Figure 26. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032) Figure 27. North America Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Country (2021-2032) Figure 28. United States Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032) Figure 33. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032) Figure 34. Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Country (2021-2032) Figure 35. Germany Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032) Figure 45. China Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032) Figure 46. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032) Figure 48. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032) Figure 49. Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Region (2021-2032) Figure 50. Japan Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Country (2021-2032) Figure 60. Brazil Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Cell and Gene Therapy Bioanalytical Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Gene-modified Cell Therapy
  • Cell Therapy
Applications
  • Non-clinical Contract Manufacturing Organizations
  • Pharma and Biopharma Companies
  • Contract Research Organizations
  • Others
Companies covered
  • BioAgilytix Labs
  • KCAS Bioanalytical Services
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, Inc.
  • Prolytix
  • Pharmaron
  • Charles River Laboratories
  • Syneos Health
  • SGS SA
  • CD BioSciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell and Gene Therapy Bioanalytical Testing Services Market by Type
  3. 1.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Gene-modified Cell Therapy
  6. 1.2.4 Cell Therapy
  7. 1.3 Cell and Gene Therapy Bioanalytical Testing Services Market by Application
  8. 1.3.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Non-clinical Contract Manufacturing Organizations
  10. 1.3.3 Pharma and Biopharma Companies
  11. 1.3.4 Contract Research Organizations
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Bioanalytical Testing Services Market Dynamics
  1. 2.1 Cell and Gene Therapy Bioanalytical Testing Services Industry Trends
  2. 2.2 Cell and Gene Therapy Bioanalytical Testing Services Industry Drivers
  3. 2.3 Cell and Gene Therapy Bioanalytical Testing Services Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Bioanalytical Testing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Perspective (2021-2032)
  2. 3.2 Global Cell and Gene Therapy Bioanalytical Testing Services Growth Trends by Region
  3. 3.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Players
  2. 4.1.1 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell and Gene Therapy Bioanalytical Testing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell and Gene Therapy Bioanalytical Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell and Gene Therapy Bioanalytical Testing Services Key Players Headquarters & Area Served
  7. 4.4 Global Cell and Gene Therapy Bioanalytical Testing Services Players, Product Type & Application
  8. 4.5 Global Cell and Gene Therapy Bioanalytical Testing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market CR5 and HHI
  11. 4.6.3 2025 Cell and Gene Therapy Bioanalytical Testing Services Tier 1, Tier 2, and Tier 3
5 Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type
  1. 5.1 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2021-2032)
6 Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application
  1. 6.1 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2032)
  3. 6.3 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BioAgilytix Labs
  2. 7.1.1 BioAgilytix Labs Company Information
  3. 7.1.2 BioAgilytix Labs Business Overview
  4. 7.1.3 BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  6. 7.1.5 BioAgilytix Labs Recent Developments
  7. 7.2 KCAS Bioanalytical Services
  8. 7.2.1 KCAS Bioanalytical Services Company Information
  9. 7.2.2 KCAS Bioanalytical Services Business Overview
  10. 7.2.3 KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  12. 7.2.5 KCAS Bioanalytical Services Recent Developments
  13. 7.3 Laboratory Corporation of America Holdings
  14. 7.3.1 Laboratory Corporation of America Holdings Company Information
  15. 7.3.2 Laboratory Corporation of America Holdings Business Overview
  16. 7.3.3 Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  18. 7.3.5 Laboratory Corporation of America Holdings Recent Developments
  19. 7.4 Pharmaceutical Product Development, Inc.
  20. 7.4.1 Pharmaceutical Product Development, Inc. Company Information
  21. 7.4.2 Pharmaceutical Product Development, Inc. Business Overview
  22. 7.4.3 Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  24. 7.4.5 Pharmaceutical Product Development, Inc. Recent Developments
  25. 7.5 Prolytix
  26. 7.5.1 Prolytix Company Information
  27. 7.5.2 Prolytix Business Overview
  28. 7.5.3 Prolytix Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Prolytix Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  30. 7.5.5 Prolytix Recent Developments
  31. 7.6 Pharmaron
  32. 7.6.1 Pharmaron Company Information
  33. 7.6.2 Pharmaron Business Overview
  34. 7.6.3 Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  36. 7.6.5 Pharmaron Recent Developments
  37. 7.7 Charles River Laboratories
  38. 7.7.1 Charles River Laboratories Company Information
  39. 7.7.2 Charles River Laboratories Business Overview
  40. 7.7.3 Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  42. 7.7.5 Charles River Laboratories Recent Developments
  43. 7.8 Syneos Health
  44. 7.8.1 Syneos Health Company Information
  45. 7.8.2 Syneos Health Business Overview
  46. 7.8.3 Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  48. 7.8.5 Syneos Health Recent Developments
  49. 7.9 SGS SA
  50. 7.9.1 SGS SA Company Information
  51. 7.9.2 SGS SA Business Overview
  52. 7.9.3 SGS SA Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 SGS SA Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  54. 7.9.5 SGS SA Recent Developments
  55. 7.10 CD BioSciences
  56. 7.10.1 CD BioSciences Company Information
  57. 7.10.2 CD BioSciences Business Overview
  58. 7.10.3 CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  60. 7.10.5 CD BioSciences Recent Developments
8 North America
  1. 8.1 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue (2021-2032)
  2. 8.2 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032)
  5. 8.3 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032)
  9. 8.5 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country
  11. 8.6.1 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue (2021-2032)
  2. 9.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country
  11. 9.6.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell and Gene Therapy Bioanalytical Testing Services Revenue (2021-2032)
  2. 10.2 China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032)
  5. 10.3 China Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032)
  9. 10.5 China Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue (2021-2032)
  2. 11.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country
  11. 11.6.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue (2021-2032)
  2. 12.2 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country
  11. 12.6.1 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell and Gene Therapy Bioanalytical Testing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst